Carregant...
Chemosensitive relapse in small cell lung cancer proceeds through an EZH2-SLFN11 axis
Small cell lung cancer is initially highly responsive to cisplatin and etoposide but in almost every case becomes rapidly chemoresistant, leading to death within one year. We modeled acquired chemoresistance in vivo using a series of patient-derived xenografts to generate paired chemosensitive and c...
Guardat en:
| Publicat a: | Cancer Cell |
|---|---|
| Autors principals: | , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5313262/ https://ncbi.nlm.nih.gov/pubmed/28196596 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccell.2017.01.006 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|